miércoles, 7 de octubre de 2026
BuscarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· March 3, 2026

Grupo Supervielle outlines 25%-30% loan growth target for 2026 as margins recover and capital strengthens

View original at seekingalpha.com
Grupo Supervielle outlines 25%-30% loan growth target for 2026 as margins recover and capital strengthens Earnings Call Insights: Grupo Supervielle S.A…
Opening lines of the source · short snapshot — read the full document at the original

Lo que extrajimos de esta fuente

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Client net financial income increased 21% sequentially, driven by lower funding costs combined with higher loan volumes and yields

    80% confidence
  • NIM expected to be between 14% and 16% in 2026

    80% confidence
  • Cost of risk projected between 6% and 6.5% for 2026

    80% confidence
  • Year-end CET1 ratio projected between 11% and 13% for 2026

    80% confidence
  • Net fee income expected to grow about 5% in real terms for 2026

    80% confidence
  • In the fourth quarter, we delivered results within our guidance range and positioned the balance sheet for industry recovery. The period was marked by elevated system-wide credit stress, which we were not immune to. However, in several key areas, we outperformed the industry.

    80% confidence
  • NPL ratio expected to range between 5% and 6% for 2026, temporarily peaking in Q1 2026

    80% confidence
  • We reported an attributable net loss of nearly CLP 20 billion in the fourth quarter, improving materially from the CLP 55 billion loss in the prior quarter. November marked a turning point with declining rates supporting better margins towards year-end.

    80% confidence
  • Real loan growth expected at 25% to 30% in 2026, led by corporate lending

    80% confidence
  • Total loans grew 8% sequentially and 37% year-over-year, driven by corporates now representing 63% of the portfolio

    80% confidence
  • No dividends will be paid in 2026 due to the 2025 loss

    80% confidence
  • We can expect sequential improvements throughout 2026...our ROE basically to move into double digits by the end of 2026

    80% confidence
  • We believe Supervielle is well positioned to participate in that expansion

    80% confidence
  • The capital level will be set by reinvestment of utilities for profit and the loan growth that we now foresee between 25% and 30% in real terms for the year

    80% confidence
  • More than 70% of transactions are digital, reinforcing both engagement and operating efficiency

    80% confidence
  • Margin recovery and strict cost control despite elevated cost of risk led to improved loss

    80% confidence
Lo que sabemos · la inteligencia detrás de esta página
En vivo desde el sustrato
Lo que estamos viendo
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
Nuestra lectura de los datos ›
Señales que seguimos
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patrones que observamos ›
Donde las fuentes discrepan
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Señalamos los conflictos abiertamente ›
Verificado recientemente
✓ Verificado con la fuente original
4,985
hechos rastreados a su fuente — y señalamos los que no se sostienen.
101 entidades seguidas4,985 hechos verificados con la fuente5,351 documentos fuente archivados
Consulta estos datos → isubstrate.com
Grupo Supervielle outlines 25%-30% loan growth target for 2026 as margins recover and capital strengthens — Source | Via News | es.VIA.NEWS